PSTV is breaking the downward trendlineIt has some potential to go up to 2.50 range. Currently sitting @ 1.88 and the volume is coming in. Grabbed some shares here as a starter.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.42 USD
−13.32 M USD
4.91 M USD
5.75 M
About PLUS THERAPEUTICS, Inc.
Sector
CEO
Marc H. Hedrick
Headquarters
Austin
Website
Founded
1996
FIGI
BBG000C1Z086
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
scalping at TF15 Hooksystem& systemDgcshort term trade in systemDgc and Hooksystem. by using the supertrend line to determine whether the trend is still there or the trend is over.
PSTV Plus TherapeuticsBounce off upward trend lines means the potential for a double exists within 4 months
$PSTV is gonna fall todayPupm&Dump trading strategy idea.
$PSTV is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,32;
stop-loss — $2,47;
take-profit — $2,02/MOC
Do not view
$PSTV Target PTs 3.30-5 and higherPlus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium NanoLiposomes, a patented radiotherapy for patients with recurrent glioblasto
$PSTV with nice gap to fillIf $PSTV finds support on the 236 it could climb for another 70-125% to fill the gap towards previous highs.
PSTV is added to the watchlist.I know nothing of this company, but the volume tells me someone is interested. It looks like it was building a cause, but I still don’t see a spring. I’ll be watching for this gap to fill and retest the trend line, which happens to coincide with a .618 fib area.
#Live but not pro, #all ideas are s
$PSTV is it time for another float mania " chat is banking " runtrading vehicle of the day or week who knows
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PSTV is 1.08 USD — it has decreased by −1.83% in the past 24 hours. Watch PLUS THERAPEUTICS, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PLUS THERAPEUTICS, Inc. stocks are traded under the ticker PSTV.
PSTV stock has fallen by −16.41% compared to the previous week, the month change is a −9.32% fall, over the last year PLUS THERAPEUTICS, Inc. has showed a −42.86% decrease.
We've gathered analysts' opinions on PLUS THERAPEUTICS, Inc. future price: according to them, PSTV price has a max estimate of 19.00 USD and a min estimate of 4.00 USD. Watch PSTV chart and read a more detailed PLUS THERAPEUTICS, Inc. stock forecast: see what analysts think of PLUS THERAPEUTICS, Inc. and suggest that you do with its stocks.
PSTV reached its all-time high on Jan 2, 2001 with the price of 1,321,875.00 USD, and its all-time low was 0.93 USD and was reached on Dec 19, 2024. View more price dynamics on PSTV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PSTV stock is 3.74% volatile and has beta coefficient of 1.51. Track PLUS THERAPEUTICS, Inc. stock price on the chart and check out the list of the most volatile stocks — is PLUS THERAPEUTICS, Inc. there?
Yes, you can track PLUS THERAPEUTICS, Inc. financials in yearly and quarterly reports right on TradingView.
PLUS THERAPEUTICS, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
PSTV earnings for the last quarter are −0.37 USD per share, whereas the estimation was −0.56 USD resulting in a 34.22% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about PLUS THERAPEUTICS, Inc. earnings.
PLUS THERAPEUTICS, Inc. revenue for the last quarter amounts to 1.46 M USD, despite the estimated figure of 1.47 M USD. In the next quarter, revenue is expected to reach 2.60 M USD.
PSTV net income for the last quarter is −2.87 M USD, while the quarter before that showed −2.94 M USD of net income which accounts for 2.24% change. Track more PLUS THERAPEUTICS, Inc. financial stats to get the full picture.
No, PSTV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 20.00 employees. See our rating of the largest employees — is PLUS THERAPEUTICS, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PLUS THERAPEUTICS, Inc. EBITDA is −13.85 M USD, and current EBITDA margin is −255.97%. See more stats in PLUS THERAPEUTICS, Inc. financial statements.
Like other stocks, PSTV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PLUS THERAPEUTICS, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PLUS THERAPEUTICS, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PLUS THERAPEUTICS, Inc. stock shows the sell signal. See more of PLUS THERAPEUTICS, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.